Pursuant to the relevant provisions of the SEBI Listing Regulations, Supriya Lifescience has informed that it enclosing Press Release for Appointment of Rajeev Kumar Jain as Chief Executive Officer & Key Managerial Personnel with effective from October 3, 2022.
The above information is a part of company’s filings submitted to BSE.